Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Herpes simplex Infection

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    March 2021
  1. WANG K, Dropulic L, Bozekowski J, Pietz HL, et al
    Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.
    J Infect Dis. 2021 Mar 15. pii: 6170962. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  2. HARPAZ R
    Reply to Johnson: Zosteriform Herpes Simplex is quite uncommon and unlikely to confound epidemiologic studies of herpes zoster.
    J Infect Dis. 2020 Nov 27. pii: 6007006. doi: 10.1093.
    PubMed    


    June 2020
  3. CASTO AM, Stout SC, Selvarangan R, Freeman AF, et al
    Evaluation of Genotypic Antiviral Resistance Testing as an Alternative to Phenotypic Testing in a Patient with DOCK8 Deficiency and Severe HSV-1 Disease.
    J Infect Dis. 2020;221:2035-2042.
    PubMed     Abstract available


    October 2019
  4. KAO CM, Goymer J, Loh LN, Mahant A, et al
    Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies that Mediate Antibody Dependent Cellular Cytotoxicity in Protecting Neonates from Herpes Simplex Virus Type 1 and Type 2.
    J Infect Dis. 2019 Oct 10. pii: 5585046. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  5. DROPULIC LK, Oestreich MC, Pietz HL, Laing KJ, et al
    A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus 2 Vaccine, HSV529, in Adults With or Without HSV Infection.
    J Infect Dis. 2019 May 6. pii: 5486075. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  6. KELLER MJ, Huber A, Espinoza L, Serrano MG, et al
    Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.
    J Infect Dis. 2019 Apr 27. pii: 5481045. doi: 10.1093.
    PubMed     Abstract available


  7. CASTO AM, Roychoudhury P, Xie H, Selke S, et al
    Large, stable, contemporary interspecies recombination events in circulating human herpes simplex viruses.
    J Infect Dis. 2019 Apr 23. pii: 5477434. doi: 10.1093.
    PubMed     Abstract available


  8. SCHMID DS
    Mixing It Up: New Insights Into Interspecies Recombination Between Herpes Simplex Virus Type 1 and 2.
    J Infect Dis. 2019 Apr 23. pii: 5477418. doi: 10.1093.
    PubMed    


    March 2019
  9. RAMCHANDANI MS, Jing L, Russell RM, Tran T, et al
    Viral Genetics Modulate Orolabial Herpes Simplex Virus Type 1 Shedding in Humans.
    J Infect Dis. 2019;219:1058-1066.
    PubMed     Abstract available


    February 2019
  10. MARRAZZO JM, Rabe L, Kelly C, Richardson B, et al
    Tenofovir gel for prevention of herpes simplex virus type-2 acquisition: findings from the VOICE Trial.
    J Infect Dis. 2019 Feb 11. pii: 5315462. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  11. AGYEMANG E, Magaret AS, Selke S, Johnston C, et al
    Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.
    J Infect Dis. 2018 Jul 17. pii: 5055244. doi: 10.1093.
    PubMed     Abstract available


  12. VAN WAGONER N, Fife K, Leone PA, Bernstein DI, et al
    Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital HSV-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-controlled Trial.
    J Infect Dis. 2018 Jul 6. pii: 5049813. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  13. SHIPLEY MM, Renner DW, Ott M, Bloom DC, et al
    Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time.
    J Infect Dis. 2018 Jun 18. pii: 5039658. doi: 10.1093.
    PubMed     Abstract available


    April 2018
  14. BRADLEY J, Floyd S, Piwowar-Manning E, Laeyendecker O, et al
    Sexually Transmitted Bedfellows: Exquisite Association between HIV and HSV2 in 21 Communities in Southern Africa in the HPTN 071 (PopART) Study.
    J Infect Dis. 2018 Apr 6. pii: 4962568. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  15. BOPPANA SB, Britt WJ, Fowler K, Hutto SC, et al
    Pathogenesis of Non-Zika Congenital Viral Infections.
    J Infect Dis. 2017;216.
    PubMed     Abstract available


  16. BURN C, Ramsey N, Garforth SJ, Almo S, et al
    An HSV-2 single-cycle candidate vaccine deleted in glycoprotein D, DeltagD-2, protects male mice from lethal skin challenge with clinical isolates of HSV-1 and HSV-2.
    J Infect Dis. 2017 Dec 5. pii: 4693944. doi: 10.1093.
    PubMed     Abstract available


    November 2017
  17. ANDREI G, Gillemot S, Topalis D, Snoeck R, et al
    The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase.
    J Infect Dis. 2017 Nov 23. pii: 4653578. doi: 10.1093.
    PubMed     Abstract available


    October 2017
  18. VAN KAMPEN JJA, Tintu A, Russcher H, Fraaij PLA, et al
    Ebola Virus Inactivation by Detergents Is Annulled in Serum.
    J Infect Dis. 2017;216:859-866.
    PubMed     Abstract available


    March 2017
  19. SIRONI M, Peri AM, Cagliani R, Forni D, et al
    TLR3 mutations in adult patients with Herpes Simplex virus and Varicella Zoster virus encephalitis.
    J Infect Dis. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  20. KAKIUCHI S, Tsuji M, Nishimura H, Yoshikawa T, et al
    Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    J Infect Dis. 2017;215:865-873.
    PubMed     Abstract available


  21. CELUM C, Hong T, Cent A, Donnell D, et al
    Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.
    J Infect Dis. 2017;215:907-910.
    PubMed     Abstract available


  22. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
    J Infect Dis. 2017;215:844-846.
    PubMed    


    February 2017
  23. SHANNON B, Gajer P, Yi TJ, Ma B, et al
    Distinct effects of the cervico-vaginal microbiota and herpes simplex type 2 infection on female genital tract immunology.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed    


  24. KAKIUCHI S, Tsuji M, Nishimura H, Yoshikawa T, et al
    The Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus 1 with the Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed    


    January 2017
  25. BERNSTEIN DI, Wald A, Warren T, Fife K, et al
    Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings from a Randomized Trial.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Abstract available


  26. COHEN JI
    Vaccination to Reduce Reactivation of Herpes Simplex Virus 2.
    J Infect Dis. 2017 Jan 11. pii: jix006. doi: 10.1093.
    PubMed    


    December 2016
  27. MESQUITA PM, Preston-Hurlburt P, Keller MJ, Vudattu N, et al
    Role of IL-32 in HIV Reactivation and its Link to HIV-HSV Coinfection.
    J Infect Dis. 2016 Dec 22. pii: jiw612. doi: 10.1093.
    PubMed     Abstract available


    December 2015
  28. FIFE KH, Mugwanya K, Thomas KK, Baeten JM, et al
    Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.
    J Infect Dis. 2015.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: